StockWatch
·

AMRUTANJAN HEALTH CARE LTD.-$

BSE: 590006

values in crores

Revenue & Profit Trend

in crores
RevenueExpenditureNet Profit
-17.4445.56108.57171.58Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27

Margin Trend

percentage
OPM %NPM %
1.538.9316.3323.73Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
PeriodQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25
INCOME
Revenue102.97-31.2%149.77+6.2%141.04+19.8%117.70+25.2%94.05-30.5%135.41+10.3%122.75+11.7%109.92
Other Income3.81-19.4%4.73+14.8%4.12-4.1%4.30-3.0%4.43-8.1%4.82+10.5%4.36+7.7%4.05
Total Income106.78-30.9%154.50+6.4%145.16+19.0%122.00+23.9%98.47-29.8%140.23+10.3%127.11+11.5%113.96
EXPENSES
Expenditure98.69-21.6%125.88+7.1%117.54+14.4%102.78+17.9%87.18-27.0%119.38+18.1%101.12+3.2%98.02
Tax1.70-64.7%4.82-30.2%6.91+31.6%5.25+76.2%2.98-47.5%5.68-15.8%6.74+62.4%4.15
PROFIT
PBT6.07-71.1%21.02-20.3%26.36+37.2%19.21+70.2%11.29-45.9%20.86-19.8%25.99+63.0%15.94
Net Profit4.37-73.0%16.19-16.8%19.45+39.3%13.96+68.0%8.31-45.2%15.18-21.2%19.25+63.1%11.80
KEY METRICS
OPM %4.09%-7.89pp11.98%-4.98pp16.96%+2.92pp14.04%+5.06pp8.98%-4.09pp13.07%-8.10pp21.17%+6.67pp14.50%
NPM %4.09%-6.39pp10.48%-2.92pp13.40%+1.96pp11.44%+3.00pp8.44%-2.38pp10.82%-4.86pp15.68%+4.94pp10.74%
EPS1.51-73.0%5.60-16.8%6.73+39.3%4.83+68.3%2.87-45.3%5.25+683.6%0.67+63.4%0.41

Corporate Events

Board MeetingAMRUTANJAN
2026
23Sep

Board Meeting

The 89th Annual General Meeting of the Company is scheduled …

BSE Filing
DividendAMRUTANJAN
2026
11Sep

Dividend

BSE Filing
Board MeetingAMRUTANJAN
2026
11Aug

Board Meeting

The meeting of the Board of Directors is scheduled to be hel…

BSE Filing
DividendAMRUTANJAN
2024
23May

₹2.6 / share

BSE Filing
Board MeetingAMRUTANJAN
2024
23May

Board Meeting

Consider and approve Audited Financial Results, Independent …

BSE Filing
Board MeetingAMRUTANJAN
2024
9Feb

Board Meeting

Consideration and approval of Un-Audited Financial Results a…

BSE Filing
DividendAMRUTANJAN
2023
23Nov

₹0.01 / share

BSE Filing
Board MeetingAMRUTANJAN
2023
10Nov

Board Meeting

Consideration and approval of Unaudited Financial Results fo…

BSE Filing